🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

322 results for “Hospital Authority, Hong Kong” Clear

  1. Vitamin D3

    Hospital Authority, Hong Kong

    Bronchiectasis

    approved small molecule active

    1 trial

  2. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  3. conbercept

    Hospital Authority, Hong Kong

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  4. conventional dose epinephrine

    Hospital Authority, Hong Kong

    Croup

    approved small molecule active

    1 trial

  5. fluticasone/salmeterol, tiotropium

    Hospital Authority, Hong Kong

    COPD

    approved small molecule active

    1 trial

  6. gastric scintigraphy

    Hospital Authority, Hong Kong

    Functional Dyspepsia

    approved other terminated

    1 trial

  7. isoniazid, rifampin, pyrazinamide

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  8. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  9. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  10. omeprazole plus amoxicillin

    Hospital Authority, Hong Kong

    Duodenal Ulcer

    approved small molecule completed

    1 trial

  11. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  12. video capsule endoscopy

    Hospital Authority, Hong Kong

    Overt Obscure Gastrointestinal Bleeding

    approved other completed

    1 trial

  13. 0 ul of ondansetron

    Hospital Authority, Hong Kong

    Blood Coagulation Disorder

    small molecule active

    1 trial

  14. 0.9% NaCl physiological saline

    Hospital Authority, Hong Kong

    Acute Respiratory Tract Infections

    small molecule active

    1 trial

  15. 18F-PMPBB3 (APN-1607) PET imaging

    Hospital Authority, Hong Kong

    Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan

    other completed

    1 trial

  16. 25% Carbohydrate solution (CHO drinking)

    Hospital Authority, Hong Kong

    Type2diabetes

    other completed

    1 trial

  17. 5-gene classification model

    Hospital Authority, Hong Kong

    ABO Blood Type Incompatible Kidney Transplantation

    other completed

    1 trial

  18. AREG-TRIGGER

    Hospital Authority, Hong Kong

    PCOS

    small molecule completed

    1 trial

  19. Abbreviated non-contrast MRI of the liver

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    other active

    1 trial

  20. Acetaminophen

    Hospital Authority, Hong Kong

    Elbow Fracture

    small molecule completed

    1 trial

  21. Andrositol Plus

    Hospital Authority, Hong Kong

    Male Infertility

    other active

    1 trial

  22. Anti-PD1

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma (NPC)

    small molecule completed

    1 trial

  23. Artificial intelligence

    Hospital Authority, Hong Kong

    Internal Disease

    other active

    1 trial

  24. Bupivacain

    Hospital Authority, Hong Kong

    Arthroplasty, Replacement, Knee

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources